.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Mallinckrodt
Boehringer Ingelheim
McKinsey
Medtronic
Chinese Patent Office
UBS
Cipla
Colorcon
Deloitte

Generated: July 25, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: oxaprozin

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Amneal Pharms Co
OXAPROZIN
oxaprozin
TABLET;ORAL208633ANDAAmneal Pharmaceuticals LLC69238-1120-1100 TABLET in 1 BOTTLE (69238-1120-1)
Amneal Pharms Co
OXAPROZIN
oxaprozin
TABLET;ORAL208633ANDAAmneal Pharmaceuticals LLC69238-1120-5500 TABLET in 1 BOTTLE (69238-1120-5)
Gd Searle
DAYPRO
oxaprozin
TABLET;ORAL018841NDAG.D. Searle LLC Division of Pfizer Inc0025-1381-31100 TABLET, FILM COATED in 1 BOTTLE (0025-1381-31)
Gd Searle
DAYPRO
oxaprozin
TABLET;ORAL018841NDAG.D. Searle LLC Division of Pfizer Inc0025-1381-34100 TABLET, FILM COATED in 1 BOX, UNIT-DOSE (0025-1381-34)
Gd Searle
DAYPRO
oxaprozin
TABLET;ORAL018841NDAG.D. Searle LLC Division of Pfizer Inc0025-1381-51500 TABLET, FILM COATED in 1 BOTTLE (0025-1381-51)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Citi
Express Scripts
Chinese Patent Office
Harvard Business School
Cerilliant
Boehringer Ingelheim
Moodys
Teva
Medtronic

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot